MétaCan
Menu
← Back to cohort
Record W2935340149 · doi:10.1161/str.48.suppl_1.15

Abstract 15: Long Term Outcomes of Intravenous Glyburide in Patients 70 Years of Age or Under: Subgroup Analysis From the Phase II GAMES-RP Study of Patients with Large Hemispheric Infarction

2017· article· en· W2935340149 on OpenAlexaff
Kevin N. Sheth, Ken Cheung, Holly E. Hinson, Bradley J. Molyneaux, Lauren A. Beslow, Gordon Sze, Ann‐Christin Ostwaldt, W. Taylor Kimberly

Bibliographic record

VenueStroke · 2017
Typearticle
Languageen
FieldMedicine
TopicAcute Ischemic Stroke Management
Canadian institutionsKimberly-Clark (Canada)
Fundersnot available
KeywordsMedicinePlaceboModified Rankin ScaleSubgroup analysisRandomized controlled trialExploratory analysisInternal medicineExact testStroke (engine)Clinical endpointSurgeryConfidence intervalIschemiaIschemic stroke

Abstract

fetched live from OpenAlex

Background: Prior evidence suggests that younger patients are at increased risk for the deleterious consequences associated with edema after large hemispheric infarction (LHI). GAMES-RP was a double-blind, randomized, placebo controlled phase 2 study. Patients presenting to 18 centers with baseline infarct volumes between 82 and 300 cm 3 on MRI were randomized 1:1 within 10 hours of symptom onset. Although the primary analysis, which included decompressive craniectomy as part of a composite endpoint, suggested no difference between groups, there was a trend toward decreased mortality for patients treated with IV glyburide. Objective: Exploratory analyses of the GAMES-RP trial suggested that overall trend of decreased mortality for patients treated with IV glyburide may be more pronounced with younger patients. We hypothesized that patients age 70 and under who were treated with IV glyburide would have improved long term outcomes compared to placebo. Methods: This exploratory analysis included the subset of patients aged < 70 who met the Per-Protocol definition: IV glyburide (n=35) and placebo (n=30). We analyzed 12-month mortality, functional outcome by analysis of the modified Rankin Scale (mRS), functional improvement on the Barthel Index (BI), and quality of life using the EQ-5D. Differences were analyzed using Fisher’s exact test except for shift analysis, which used a two sided Mann-Whitney test. Results: Subjects treated with IV glyburide had lower mortality at 12 months (14% vs 40%, p=0.025, OR 4.00). Shift analysis revealed a trend towards improved functional outcome in IV glyburide treated patients (OR 2.24; p=0.080), higher score on the BI (mean 60.1; SD 37.9 vs mean 39.5; SD 40.1, p=0.03), and higher score on the EQ-5D (mean 0.49; SD 0.31 vs mean 0.33; SD 0.32, p=0.04). Conclusion: This post-hoc analysis suggests that patients under 70, who may be at highest risk for poor outcomes secondary to edema after large hemispheric infarction, may have improved survival, better functional outcome and improved quality of life following treatment with IV glyburide. A prospective study is required in this population in order to definitively establish that IV glyburide can improve outcome. Registry: NCT01794182

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.011

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.003
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0030.006
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.014
GPT teacher head0.282
Teacher spread0.268 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueStroke→Same topicAcute Ischemic Stroke Management→French-language works237,207→